<sup>18</sup> F-FDG and <sup>18</sup> F-Fluorocholine PET as Prognostic Biomarkers in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Prospective Multicenter Study
18 F-FDG and 18 F-Fluorocholine PET as Prognostic Biomarkers in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Prospective Multicenter Study
A. Fouquier, Julie Vincent, Héloïse Bourien, Xavier Palard-Novello et al.
Journal
Journal of Nuclear Medicine
Topics
Hepatocellular Carcinoma Treatment and Prognosis
article
18 F-FDG and 18 F-Fluorocholine PET as Prognostic Biomarkers in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib: A Prospective Multicenter Study
Centre National de la Recherche Scientifique (FR), Université de Bordeaux (FR), Inserm (FR), Université de Bourgogne (FR), Centre Georges François Leclerc (FR), Centre Hospitalier Régional et Universitaire de Nancy (FR), Centre Hospitalier Universitaire de Reims (FR), Centre Eugène Marquis (FR), CHU Dijon Bourgogne (FR), Maison des Sciences sociales et des Humanités de Dijon (FR), Institut Jean Godinot (FR), Université de Reims Champagne-Ardenne (FR)